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In order to investigate the biologic signifi cance of HLA-
DR expression by human keratinocytes, we have examined 
the possibility that DR-positive keratinocytes becom e al-
loantigen presentin g cells fo r res ting T cells in the presence 
of in terl eukin-2. U sing thi s sys tem , gamma interferon-
trea ted , D R-positive keratin ocy tes stimulate the prolifer-
ation of allogeneic, res tin g T cell s approximately 3-fold 
whereas non-ga mma interferon- trea ted , DR-nega tive ke-
ratinocy tes do not. Because a monoclonal antibody against 
recombin ant gamma interferon inhibits thi s proliferation, 
the stimulation is dependent on pre-incubation with gamma 
interfe ron . B y contras t, since the stimulation is not inhib-
ited by a monoclonal antibody against HLA-DR, it is no t 
clea r that the stimulation is due to class II antigen expression 
by kera tinocytes. T o rule out that ga mma interferon in-
Recent studies have shown that hLlln an reco mbinant ga mma interferon (r1 FN-ga mm a) induces the syn-thes is and express ion of HLA-DR antigen, a class II antigen of the maj o r histocompatibility complex (MHC), in cultu red , human kera tinocytes (1,2]. This 
antigen is necessa ry for antigen presentation by macrophage to 
circulating T lymphocytes (3]. In order to determine the biologic 
consequences of HLA-DR expression by kera tinocytes, we in-
ves ti ga ted the ability of th ese cells to stim ulate allogeneic pe-
ripheral blood mononuclear leukocytes (PB ML) in vitro and found 
th ese interactions to be complex [4]. For exa mple, cultured ke-
ratinocytes produce prostaglandin E2 (PGE2), w hich inhibits PBML 
proliferation, and r1FN-gamma grea tl y increases PGE2 produc-
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Abbreviations: 
AZ: sodium azide 
EDTA: ethylenediamine tetraacetate 
FACS: flu orescence-activa ted cell so rter 
FCS: fetal ca lf serum 
GYHD: graft versus hos t disease 
HLA-DR - : HLA-DR nega ti ve 
HLA- DR +: HLA-DR positive 
[JH]Thd: tri tia ted thymidine 
creases the expression of class I antigens, leading to stim-
ulation of res ting T cells on that bas is, we determined 
whether gamma interferon trea tment enhances class I an-
tigen expression by keratinocy tes. T he lymphokine trea ted 
cells did not demonstrate more class I antigen expression 
than untrea ted keratinocytes. Thus, the observed stimu-
lation of allogeneic, resting T cells by ga mma interferon-
trea ted keratinocytes in the presence of IL-2 is not due to 
in creased class I antigen express ion but is due to other cell 
surface antigen(s) induced by recombinant gamma inter-
feron trea tment . These results sugges t that gamma inter-
feron-exposed keratinocytes in the presence of interleukin-
2 m ay augm ent the activation of resting T lymphocytes 
and , in this manner, m ay contribute to cutaneous inflam-
mation. J Invest D ermato/ 89:464- 468, 1987 
tion [4] . Moreover, our results sugges ted that HLA-DR-positive 
(HLA-D R+), allogeneic keratinocytes when incubated with PBML 
caused ga mma interferon secretion which can represent a sign of 
PBML activa tion. These PBML did no t proliferate markedly, 
however, as documented by low levels of(3H)thymidine WH]Thd) 
incorporation as well as by no increase in numbers ofPBML [4) . 
Umetsu and associa tes have repo rted recentl y that HLA-DR + 
fibroblas ts but not HLA-D R-negative (HLA-DR - ) fi broblasts 
can present tetanus toxoid to T cell clones but not to resting T 
(T n) cells (5). Furtherm ore, DR + fib roblas ts had the capacity to 
stimulate allogeneic T n cells but onl y in the presence of interleu-
kin-2 (IL-2) (5). Since Til cell proli fe rati on requ ires two sequential 
signals: first, "activation " as a response to fo reign antigen, and 
secondl y, a proEferative signal provided by IL-2 [6). we in ves-
lL-1: interleukin-l 
KLR: kera tinocyte lymphocyte reaction 
KTG F: kera tinocyte-derived T-cell growth facto r 
mAb: monoclonal antibody 
MHC: maj or histocom patibility complex 
PBML: peripheral blood mononuclear leukocy tes 
PBS: phosphate-buffe red saline 
PGE 2: pros taglandin-E2 
RBC: red blood cells 
rlFN-gamma: recombinallt gamm a interferon 
rlL-2: recombinant interleukin-2 
R/M-FITC: fluorescein isothiocyanate conjuga ted rabbit anti mouse 
[gG 
SRBC: sheep red blood cells 
Til: res ting T cell s 
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tigated the effects of recombinant IL-2 (r1L-2) on the ca pacity of 
cultured, HLA-DR + kera tinocytes to stimulate allogeneic T il cells. 
MATERIALS AND METHODS 
Lymphokines and Monoclonal Antibodies (mAb) Ultra-
pure interleukin-l (IL-l ) (specific activity B X 106 U / f-Lg protein) 
wasobtained from Genzyme (Boston, Massachusetts), and a highl y 
punfied preparation of r1L-2 was obtained from Ed Engleman, 
Stanford, California. The mA b L243 was obtained from Becton 
D ickinson, Mountain View, California and also as tiss ue culture 
sup ernatant (azide free) from R. Levy, Stanford, California. The 
mAbs 17F12 (which stains all T cells) and CA1.41 (which labels 
HLA-DR) were obtained from Ed Engleman [7,BJ. The r1FN-
gamma and mAb against r1FN-gamma were a gift of M . Shepard, 
Genen tech, Inc., South San Francisco , California, and mAb PA 
2.6 against class I antigen was contributed by Peter Parham, Stan-
fo rd, California [9J. 
lnununoftuorescence Staining and FACS Analysis One 
milljon epidermal cells were sta ined for 30 min with a murine 
mAb diluted in 5% heat-inactivated, fetal calf serum (FCS) in 
phosphate-buffered saline (PBS) containing 0.02% sodium azide 
(AZ) as described previously [1 OJ. The cell s then were washed 
w ith 5% FCS/PBS/ AZ, stained with fluorescein isothiocyanate-
cC;>njug.ated rabbit antimouse IgG (R/M-FITC) (lC N [mmuno-
bIOlogIcals, Lisle, IL.) for 30 min , washed with and then resus-
pend ed in 5% FCS/ PBS/ AZ. The number offluorescent cells was 
determined by fluorescence microscopy or FACS analys is [1 0J. 
Isolation of Resting T Cells Peripheral blood mononuclea r 
~eukocytes were collected by Ficoll-Paque (Pharmacia Fine Chem-
ICalS, Pisca ta way, N ew Jersey) separation of defibrin ated blood 
as d escribed [IIJ. The cells were washed with PBS and res us-
pended at 5 X 106 ceUs/ml in 40% absorbed FCS in PBS. Fres h 
sheep red blood cells (SRBC) were washed 3 times with PBS and 
adjusted to 3% v/v in 40% absorbed (on SRBC) FCS/PBS. Eq ual 
volumes of 3% SRBC and PBML were mi xed gentl y. T en to 
twenty milliliters of this cell suspension was layered on 10 ml 
FicoU-Paque, incubated on ice for 30 min , and centrifuged at 2000 
rpm at 4°C for 30 min. The interface, supernatant, and fico ll 
layers were removed by suction. To remove the SRBC the pellet 
was lysed with 10 ml ACK buffer (0.B74% NH.tCI, 0. 1 % KHC03, 
0.0037% EDTA at pH 7.4) , vortexed and incubated for 5 min at 
room temperature [BJ. T en ml of RPMI 1640 (Gibco, Grand 
Island, N ew York) plus 10% heat-in activa ted, pooled human 
serum and 2 mM L-glutamine (complete RPMI medium ) was 
add e d , the T cells were spun out and res uspended in 10 ml com-
plete RPMI medium . 
To remove activated, DR + cells, the isolated T ceUs were washed 
once wi th PBS, incubated on ice fo r 1 h in an antibody mixture 
(an ti-Leu 10, anti-HLA-DR and Ca 1.41 [a mAb against HLA-
DR]) and the DR + T cells and Leu 10 positive cells were lysed 
with complement (Low-Tox-H rabbit complement, Cedarlane 
Labs Ltd ., Hornby, Ontario, Canada) for 45 min at 37°C [1 2J. 
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Fi ve milliliters of complete RPMI was added; the remaining cells 
(Til cells) were spun, res uspended and counted. 
Keratinocyte-Lymphocyte Reaction (KLR) Single cell sus-
pensions of norm al skin obtained at the time of face lift surgery 
were prepared according to the method of Liu and Karasek [1 3J. 
Small , round , viable cells were seeded on 3.5 cm coll agen coa ted 
Petri dishes (Lux, Flow Laboratories, McLean, Virginia) or 96-
well fl at bottom micro titer plates (Linbro , Flow Lab. ) in Dul-
becco's modified Eagle's medium (D MEM) containing 1.4 mM 
calcium , supplemented w ith 10% heat-inactiva ted FCS, 50 f-Lg/ml 
of gentamicin , and 2 mM L-glutamine (complete mediLlln) as 
described previously [4J. Routinel y, 2.5-5 .0 x 104 viable cells 
were seeded per fl at bottom microtiter well . Viability as deter-
mined by trypan blue exclusion immediately following trypsin-
iza ti on was 90% or better. The cells were maintained in a hu-
midified incubator with 5% CO2 :95% air at 37°. The rlFN-
ga mma (100 U / ml) and indomethacin (Sigma C hemical Co. , St. 
Louis, Missouri) (1 J.Lg/ml) were added 2 to 3 days after cell 
seedin g. Just befo re additi on of allogeneic Tn cells (lOS cells/well), 
the keratinocyte cultures were irradiated w ith 2,000 rads using a 
Cesium source, washed twice to remove r1FN-gam ma, and the 
KLR was set up in complete RPMlmedium plus indocin (1 f-Lg/ml) . 
The keratinocytes were irradiated to prevent proliferation of these 
cell s in th e microtirer wells. [nterl eukin-2 (5U/ml) was ad ded l 
right after the addition of th e Tn cells. The KLR was set up in 
complete RPMI medium p lus indocin (1 f-Lg/ml). After 6 da ys of 
incubation, 10 f-LI of 0.1 mCi/ mP[HJThd (sp ac t 6 Ci/ Illmol; 
(lC N , Irvine, Californi a» were added per well and the cultures 
harvested IB h later on a PHD cell harves ter (Cambridge Tech-
nology, Ca mbridge, MA) [4J . 
RESULTS 
HLA-DR + Keratinocytes Do Not Stimulate Allogeneic 
Resting T Cells After HLA-D R antigen expression was in-
duced on keratinocytes g rown on co ll agen-coa ted microtiter wells 
by incubation with rlFN-ga mma (100 U/ ml) , the cells were washed 
carefu ll y and allogeneic Tn cells were added (10 ccllss/well). After 
7 days of incubation, DR + keratinocytes alone did not stimulate 
proli feration of Tn cells as moni tored by 3[HJT hd incorporation 
(Table I) . 
Effects of Exogenous IL-1 and IL-2 on the KLR Using DR+ 
Keratinocytes Since one explanation for this lack of stimulation 
might be that the DR + cells in the KLR are not able to provide 
enough [L-1 and/o r IL-2 to support proliferation of Tn cells or 
that the keratinocytes might produce an inhibitor of these 2 cy-
tokines, we added exogenous [L-l and IL-2 to the KLR. Addition 
of 1 U / mIIL-l did no t ca use the DR + kerarinocytes to stimulate 
all ogeneic T n cells (Table I). By contrast , add ition of exogenous 
IL-2 (5 U/ ml) res ulted in an approx imately 3-fold stimulation of 
allogeneic Tn cells by DR + compared to DR - kera tin ocy tes (Ta-
ble I). T his type of ex periment, using 2 different responder Tn 
cells each time, showed the sa me trend on 5 separate occasions. 
Table 1. Stimulation of Allogeneic T n Cells by DR + Keratinocytes in the Presence of IL-2 
"I Utlll i IL-1 
' 5 Utllli IL-2 








IL-1 + IL-2 
Response of Allogeneic T" cell s (cpm) 
DOllar A 
416 ± 13 
1,5 12 ± 1,762 
3,743 ± 1,247 
3,151 ± 150 
275 ± 144 
342 ± 11 2 
11 ,238 ± 652 
11,474 ± 3,50 1 
Donor B 
35 1 ± 85 
606 ± 159 
1,570 ± 348 
1,407 ± 270 
343 ± 156 
457 ± 247 
4,966 ± 1,515 
4.581 ± 1,386 
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Table IL Effect of Preincubati on With a M onoclonal Antibody Again st Gamma Interferon on th e Ca pacity of Ga mma 
Interferon-Treated Keratin ocytcs to Stimulate All ogcneic TH Cell s" 
Addition 1 Addition 2 
no ne no ne 
I11Ab against r1FN-ga llllll a 
Ilo ne 
rIFN-gaml11a mAb aga inst rIFN-ga lll1ll 3 
"A ll of the microtiter we lls received 5 U/m l IL-2 . 
The add ition of IL-l plus IL-2 did not in crease the levels of in-
corpo ration of r3H]Thd above those seen with IL-2 alone (Tab le 
I). Th us, enough IL-l appears to be present in the KLR to acti va te 
the TH cells m aximally. 
Effect of the Addition of mAbs Against rIFN-gamma and 
HLA-DR on the KLR To determine w hether a mAb against 
r1FN-ga mm a wou ld inhibit the KLR (using on + keratin ocytes 
plus IL-2), we added thi s mAb (300 neutralizin g U / ml) to the 
keratinocytes in a separare series o f mi crotiter plates at the sa ill e 
time as the rIFN-ga mlll a (100 U / ml) was added. Ar the end o f 
the 4 day incubation , we harvested representative mi crotiter w ell s 
and sta in ed the keratinocytes with mAb against HLA-DR and 
determin ed cell fluorescence usin g fluorescence mi croscopy. Wells 
that had received on ly r1FN-gaml11 a showed bri ght flu o rescence 
on about 60% of the cells. The keratinocytes that had received 
rh e r1FN-ga l11ma plus the mAb aga inst this IYl11phokin e showed 
on ly a few weakly fluorescent cells (less than 5%). Thus, the mAb 
against r1FN-ga ml11 a almost tota lly inhibited HLA-DR expres-
sion by keratinocytes . To representative mi crotiter well s seeded 
in'parallel in thi s experim ent, we added allogeneic T 1( ce lls plus 
IL-2 and Illonjtored in co rporation of [3H]Thd 7 days later. The 
concomittant addition of a mAb against r1FN-ga mm a inhibired 
the stimulation of allogeneic TH cells by r1FN-ga mm a trea ted cells 
(Table II ). Thus, a cell surfa ce anti gen indu ced by r1FN-ga mm a 
appea rs to be responsible for th e observed stimulation b y DR + 
keratinocy tes. 
To determine whether a mAb aga inst HLA-DR (L243) would 
inhibi t the stimul ation of all ogeneic Tn cells by DR + keratin o-
cytes, we in cubated the keratinocytes w ith L243 (1 : 50 dilution 
of tissue cu lture supernatant) in th e microtiter wells durin g the 
entire 7 day in cubation with T,( cells (Table III ) . Usin g 2 different 
responders, and repeated on 2 separate occasions, L243 did no t 
inhibit the stimul ation of allogeneic res tin g T R ccll s by DR + 
keratinocy tes in thc presence of exogenou s IL-2; howevcr, in 
Response of All ogeneic T" Cell s (cpm ) 
Donor A 
1, 132 ± 74 
1, 18 1 ± 78 
6,548 ± 2,003 
1,97<) ± 639 
Donor B 
5.485 ± 780 
4,858 ± 1,252 
13,417 ± 2,20 1 
5. 30 1 ± 1,893 
neither o f these experim ents did the mAb inhibit the mixed lym-
phocy te reaction (MLH) performed in parallel. On o ther occa-
sions, however, we did o bse rve abo ut 50% inhibiti on of th e MLR 
by mAb L243 at the 1 :50 dilution. In a separate ex perim ent using 
immunofluorescence, we also determined w hether L243 would 
bind to DR + keratinocytes at th e diluti on of th e supern atant used. 
We found th at supernatant L243 diluted 1: 50 binds to the HLA-
DR antigen expressed by keratinocytes after incubation with r1FN-
ga mm a. 
Effect of rlFN-gamma on Expression of Class I Antigens 
of the MHC It has been repo rted that ga mma IFN stimulates 
the ex press ion of class I anti gens in so me murin e tiss ues [1 4]. 
Therefo re, we exa min ed whether rIFN-ga I11ma enhances cl ass I 
antigen ex pression by hum an kera tin ocytes. We in cubated ke-
ratin ocy tes w ith 100 U / ml r1 FN-ga lllm a for 4 da ys and deter-
mined class I anti gcn ex press ion at the end of this time using 
stai nin g w ith IllAb PA 2. 6 and FA CS analys is. N o stimulation 
of class I anti gen occurred (no t show n). In a parallel series of 
cultures, do ne as cO l1 trols, . the ' r1FN-ga mJ11a was capable of in-
du ction of class II anti gen exp ress ion by these cells . 
DI SC U SSION 
HLA-DR + but not HLA-DR - keratin ocytes stimul ate the pro-
li ferat ion of all ogeneic T H cell s in the presence of exogenous 
IL-2. Without the additi on of rlL-2, DR + keratinocytes do not 
stimulate all ogeneic T'l cell s. This result is in ag reement wi th a 
recent reporr us ing a murin e m odel [15]. In the presence of 
IL-2, howeve r, DI~ + keratinocy tes ca n stimul ate TH cells to pro-
liferate. Sin ce no m ac ropha ge o r o ther antigen-presentin g cells 
are present in the stimulatin g cell population in our sys tem , DR + 
keratinocy tes appear to act as all oa ntigen-prcscnting cells. Prein-
cubation of the keratin ocytes w ith a mAb against rIFN-gamma 
in the presence of rIFN-ga mm a g rea tl y redu ces induction of HLA-
on. antigen ex pression by keratinocytes and conco mitantl y in-
Table III. Effect of a Monoclonal Antibod y Against HLA-DR on Response of Allogeneic T 1( Cells to DR + Keratin ocy tes 
Keratinocyte Phenotype" 












I!This m Ab has th e sam e isotypc as L243 and serves as J contro l. 
'Statistica ll y significant s timulation (I' < 0.05). 
"No statistica ll y significant inhibition (I' > 0.05). 
Il.csponse of Allogeneic TH Cells (cpm) 
Donor A Donor B 
2.48 1 ± 82 1 1,492 ± 187 
3.355 ± 1,605 1,584 ± 3 13 
2.063 ± 463 1,378 ± 21 1 
6,-\85 ± 1,536' 3, 231 ± 983' 
10,087 ± 5,957 5. 377 ± 755 
3,956 ± 1,035" 3,094 ± 1,777.1 
Response of PBML to Allogeneic irrad iated PBML (cpm ) 
DOllar A DOlla r B 
24, 124 ± 6.990 
33,023 ± 5,578 
18, 744 ± 2,496 
30,869 ± 3,727 
45,087 ± 3,837 
26,807 ± 1,6 11 
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rubits the ca pacity of these keratinocytes to act as alloantigen-
presenting cells. Thus , the proliferati ve response of Til cell s to 
rIFN-ga mm a-trea ted keratinocytes is mediated by an effect of 
rIFN-gamma, not an impurity in th e rlFN-gamma preparation . 
Moreover, it appea rs likely that the stimu lation is due to expres-
sIo n of HLA-DR since expression of this antigen is correlated to 
the keratinocytes ' ca pacity to stimulate the all ogeneic Tn cells . 
Smce a mAb aga inst HLA-DR did not ab rogate the capacity of 
DR + keratinocy tes to stimulate all ogeneic Til cells, w e can not 
say w ith certainty that the stimul ation is due to DR expression . 
In this connection, in our hands, the mAb L243 inhibited the 
classic mi xed lymphocyte culture by m aximall y 50% and in sev-
eral ex periments no inhibition at all occurred. Thus, from our 
data it is unclear w hether the in ability of mAb L243 to inhibit 
the stimulation of allo geneic Tn cells by DR + keratinocytes is 
due to vaga ri es of the mAbs against HLA-DR [1 6, 17] or th at the 
observed stimulatio n is due to an antigen o ther than DR. 
Other class II antigens, such as HLA-DR and HLA-DQ, have 
been described [18-20]. It is conceivable that these antigens are 
also induced by rIFN -ga mma and that they are res po nsible for 
the observed stimulation. Experiments are currentl y in. prog ress 
to d etermine whether DQ and DP expression ca n be induced on 
kera tinocytes by rIFN-ga mma . 
The OKT8 + subpopulation of peripheral blood T cells can 
recognize class I anti gens and can respond to th ese antigens by 
proliferation in the presence of Iymphokines such as [L-2 [17]. 
Since it has been reported that rIFN-ga m ma induces increased 
expression of class I antigen of the MHC in <:ertain murine tiss ues 
[1 4], we determined w hether an increased expression of class I 
antigen might explain the observed stimulation of restin g T cells 
by rIFN-ga mma trea ted keratinocytes. Our data do not indicate 
tha t rIFN-ga mma induces increased expression of this antigen on 
these cells. On th e other hand , we can not rule o ut the possibility 
tha t another cell surface antigen is induced b y r1FN-ga mma and 
that this antigen either alone or in conjunction with a class II 
antigen is responsibl e for stimulation of the allogeneic T n cells. 
For exa mpl e, a non-H-2 alloantigen (Epa-1 ) that m ay represent 
a histoco mpatibilit y antigen has been described in mice [21]. In 
this rega rd, one of us has recentl y observed th at treatment of 
keratin ocytes with rIFN-ga mma strongly enhan ces the binding 
of a llogeneic PBML to the keratinocytes [22]. Thus, in addition 
to HLA-DR, rIFN-ga mma ma y induce other cell surf.lce antigens 
im portant in cell-cell recognition. 
The reason for the necessity to add exogenous IL-2 in order to 
obtain stimulation in the KLR usin g DR + cell s is unclear. Usin g 
a ITlurine system , it has been demonstrated that epidermal cells 
secrete an IL-2 like factor (KTGF) [23]. Possibly , in our system 
using hum an cell s, not enough IL-2 is generated to dri ve the 
reaction. Alternativel y, usin g DR + cells a sm all amount of an 
inhibitor of IL-2 is genera ted and this ca n be overcome by the 
addi tion of excess IL-2. Ano ther poss ibility is that , in this rega rd , 
the murine skin is different from the human. Other differences 
between the murine and hum an epidermis have recently been 
docu mented . For exa mpl e, human epidermis docs not ap pea r to 
con tain a Thy-l + cell [24], and murin e r1FN-ga mma does not 
cause la expressio n on murine keratinocytes (G. Kreuger, personal 
communi ca tion). 
Schuler and cowo rkers have reported that Tn cel ls require a 
dendritic cell (i.e., Langerh ans cell) to ini tia te proliferation [25] . 
Thus, cell surface expression ofHLA-DR by a non-bone m arrow 
deri ved cell (i. e. keratinocyte, fibroblast, endothelial cell) is not 
sufficient in itself to provide all the co mpl ex proliferati ve signals 
to Tn cells . Our res ults sugges t, however, that if a source of 
IL- 2 is present, DR + keratinocytes may playa role in the affe rent 
limb of th e immune res ponse. 
The experimental results documented here may ex plain w hy 
DR + keratinocytes occur in contact dermatitis and herpex simplex 
infection [26]. Conceiva bl y, induction of DR expression by ke-
rarinocytes is a m echanism by wh ich the bod y increases the num-
ber of antigen-presentin g cells in a localized area. [n this view, 
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these DR + keratinocytes (plus foreign antigen and hos t IL-2) 
would be ca pable of stimulatin g proliferation of hos t lymph o-
cytes. In some cases, this interaction of DR + keratinocytes w ith 
lymph ocytes m ay not be turned off by th e hos t and could th en 
result in such lymphocyte- m ed iated skin diseases as lichen pl an us 
and lupus eryth ematosus [27J . Another possible mechani sm for 
th e etiol ogy of lichen pl anus as well as autoimmune diseases is 
that the expression of DH in conjun cti on with o th er ce ll surface 
antigens nati ve to the surface of thi s norm all y DR - cell ca n initiate 
proliferative signals in auto logous lymphocytes [28]. Finall y, the 
first step in chronic graft versus hos t disease (G VHD) m ay be 
activation and pro li feration of circulating, hos t T helper cells [29J. 
The production of all oreactive, cytotoxic T cells may represent 
a second (later) step in th e process. T his m ay explain w hy the 
presence of cytotoxic T cells alo ne is not sufficient to induce 
GVHD in an imal m odel s [30J. Experiments are currentl y in prog-
ress in this labo ratory to further clarify these issues. 
We previously have repo rted data w hi ch sugges ted that cul-
tured keratinocytes secrete a substance w hi ch inhibits PBML pro-
liferati on . T he current ex periments do not furth er clarify this 
observation. The stimulation o f Til cells o bserved in most of the 
ex perim ents, however, appeared to rela te in versely to th e number 
of keratinocytes seeded (no t show n). Thus, in one of th e later 
experiments in w hi ch we had seeded 2 different concentrations 
of kera tinocytes in two separate mi crotiter plates, we saw stim-
ulation only in the plate seeded w ith 2.5 X 104 keratinocy tes /well 
but saw no stimulation in th e plate seeded with 5 x 104 cells/ well 
in w hi ch the media had turned very acid by the time the Til cells 
were harves ted . B y conrras t, stimulation of Tn cells increased 
when m ore Til cells were added to th e mi crotiter well s. Although 
the number of viable keratinocytes seeded C3 n be meas ured , the 
Ilumber of cells that attach and their rate o f growth cannot be 
predicted accuratel y. Therefo re, we seeded mi crotiter plates with 
2 concentration s o f keratin ocy tes fo r the later ex periments and 
then chose the plate which showed preconfluent keratinocytes to 
perform the assay usi ng T n cells. 
The lack of stimulation o f all ogeneic Til cells by keratinocytes 
(D R + or D R - ) in the absence of exogenous IL-2 may ex pl ai n 
th e lack of rej ecti on of cultured, all ogeneic epiderm al cell sheets 
recentl y reported by Thi volet and co lleagues [31] . These cultured 
epiderm al cells presumably deprived of Langerhans cells by cul-
ture in vitro [32,33J would not provide a source of class II antigen 
and th erefo re may avoid detection by circulating hos t immune 
co mpetent cells, either beca use of th eir anatomi c loca tion in the 
upper epidermis o r beca use DR + cells are needed to attract cir-
culating lymphocytes to the epidermis [341. 
Finall y, these results underscore the co mplex ity of immune 
reactions in the skin . The keratin ocyte ca n no longer be viewed 
as merely providing a barri er to separate the external and intern al 
milieu. Rather, it seems likel y tha t the keratinocyte, after ex posure 
to ga mm a interferon, may playa role in initi ating further inter-
actions wi th th e immune system. 
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